<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, CA USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25875009</article-id>
      <article-id pub-id-type="pmc">4397011</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0124288</article-id>
      <article-id pub-id-type="publisher-id">PONE-D-15-00526</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Fusion of the Genes <italic>EWSR1</italic> and <italic>PBX3</italic> in Retroperitoneal Leiomyoma with t(9;22)(q33;q12)</article-title>
        <alt-title alt-title-type="running-head">Fusion of the Genes <italic>EWSR1</italic> and <italic>PBX3</italic> in Retroperitoneal Leiomyoma</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Panagopoulos</surname>
            <given-names>Ioannis</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
          <xref rid="cor001" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gorunova</surname>
            <given-names>Ludmila</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bjerkehagen</surname>
            <given-names>Bodil</given-names>
          </name>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Heim</surname>
            <given-names>Sverre</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff004">
            <sup>4</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff001">
        <label>1</label>
        <addr-line>Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway</addr-line>
      </aff>
      <aff id="aff002">
        <label>2</label>
        <addr-line>Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway</addr-line>
      </aff>
      <aff id="aff003">
        <label>3</label>
        <addr-line>Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway</addr-line>
      </aff>
      <aff id="aff004">
        <label>4</label>
        <addr-line>Faculty of Medicine, University of Oslo, Oslo, Norway</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Lee</surname>
            <given-names>Sean Bong</given-names>
          </name>
          <role>Academic Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
        <addr-line>Tulane University School of Medicine, UNITED STATES</addr-line>
      </aff>
      <author-notes>
        <fn fn-type="conflict" id="coi001">
          <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
        </fn>
        <fn fn-type="con" id="contrib001">
          <p>Conceived and designed the experiments: IP. Performed the experiments: IP LG BB. Analyzed the data: IP LG. Contributed reagents/materials/analysis tools: IP LG BB SH. Wrote the paper: IP SH.</p>
        </fn>
        <corresp id="cor001">* E-mail: <email>ioannis.panagopoulos@rr-research.no</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>10</volume>
      <issue>4</issue>
      <elocation-id>e0124288</elocation-id>
      <history>
        <date date-type="received">
          <day>6</day>
          <month>1</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>3</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-year>2015</copyright-year>
        <copyright-holder>Panagopoulos et al</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0124288.pdf"/>
      <abstract>
        <p>Retroperitoneal leiomyoma is a rare benign smooth muscle tumor almost exclusively found in women and with histopathological features similar to uterine leiomyomas. The pathogenesis of retroperitoneal leiomyoma is unclear and next to nothing is known about the cytogenetics and molecular genetics of the tumor. We present here a retroperitoneal leiomyoma with a t(9;22)(q33;q12) as the sole karyotypic aberration. The translocation resulted in an <italic>EWSR1-PBX3</italic> fusion gene in which exon 9 of <italic>EWSR1</italic> (nucleotide 1320 accession number NM_013986 version 3) was in-frame fused to exon 5 of <italic>PBX3</italic> (nucleotide 824 accession number NM_006195 version 5). The <italic>EWSR1-PBX3</italic> fusion transcript codes for a 529 amino acids long chimeric EWSR1-PBX3 protein which contains the N-terminal transactivation part of EWSR1 and the homeodomain of PBX3. The present study, together with our previous finding of a retroperitoneal leiomyoma with t(10;17)(q22;q21) as the sole karyotypic aberration and a <italic>KAT6B-KANSL1</italic> fusion gene, indicates that retroperitoneal leiomyomas may be characterized by fusion genes coding for chimeric proteins. However, cytogenetic and molecular heterogeneity exists in these tumors and it is too early to tell how many and which different pathways lead to retroperitoneal leiomyomagenesis.</p>
      </abstract>
      <funding-group>
        <funding-statement>This study was supported by grants from the Norwegian Cancer Society and the Norwegian Radium Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="3"/>
        <table-count count="0"/>
        <page-count count="9"/>
      </counts>
      <custom-meta-group>
        <custom-meta id="data-availability">
          <meta-name>Data Availability</meta-name>
          <meta-value>All relevant data are within the paper.</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <title>Data Availability</title>
      <p>All relevant data are within the paper.</p>
    </notes>
  </front>
  <body>
    <sec sec-type="intro" id="sec001">
      <title>Introduction</title>
      <p>Retroperitoneal leiomyoma is a rare benign smooth muscle tumor almost exclusively found in women [<xref rid="pone.0124288.ref001" ref-type="bibr">1</xref>&#x2013;<xref rid="pone.0124288.ref003" ref-type="bibr">3</xref>]. Although anatomically distinct from their uterine counterparts, they have several pathological and histological features in common with uterine leiomyomas, including hyaline fibrosis, alternating myxoid change or trabecular patterns, and positivity for estrogen and progesterone receptors [<xref rid="pone.0124288.ref001" ref-type="bibr">1</xref>&#x2013;<xref rid="pone.0124288.ref003" ref-type="bibr">3</xref>]. The cytogenetic and molecular genetic features of retroperitoneal leiomyomas remain largely unexplored as in the 2013 edition of &#x201C;WHO classification of tumours of soft tissue and bone&#x201D; there is no information about the genetics of these tumors [<xref rid="pone.0124288.ref004" ref-type="bibr">4</xref>]. Recently, we reported the first cytogenetically analyzed retroperitoneal leiomyoma which had a t(10;17)(q22;q21) as the sole karyotypic aberration [<xref rid="pone.0124288.ref005" ref-type="bibr">5</xref>]. Using RNA-sequencing we could demonstrate that the molecular consequence of the translocation was fusion of the <italic>KAT6B</italic> gene on 10q22 with the <italic>KANSL1</italic> gene (official full name: KAT8 regulatory NSL complex subunit 1) from 17q21 [<xref rid="pone.0124288.ref005" ref-type="bibr">5</xref>].</p>
      <p>We present here the second cytogenetically analyzed retroperitoneal leiomyoma. The tumor cells were found to carry a t(9;22)(q33;q12) resulting in a fusion gene consisting of parts of <italic>EWSR1</italic> (from 22q12.2) and <italic>PBX3</italic> (from 9q33.3).</p>
    </sec>
    <sec sec-type="materials|methods" id="sec002">
      <title>Materials and Methods</title>
      <sec id="sec003">
        <title>Ethics statement</title>
        <p>The study was approved by the Regional Committee for Medical and Health Research Ethics, South-East Norway (REK S&#xF8;r-&#xD8;st, Norge, <ext-link ext-link-type="uri" xlink:href="http://helseforskning.etikkom.no/">http://helseforskning.etikkom.no</ext-link>), and written informed consent was obtained from the patient.</p>
      </sec>
      <sec id="sec004">
        <title>Case history</title>
        <p>A 26-year-old female presented with a slowly growing retroperitoneal tumor. A resection was performed and a 7.5 cm large tumor was removed. Microscopical examination showed fascicles of long spindle-shaped cells with eosinophilic cytoplasm surrounded by loose fibrous matrix (<xref rid="pone.0124288.g001" ref-type="fig">Fig 1A</xref>). Immunohistochemistry demonstrated positive staining for desmin (<xref rid="pone.0124288.g001" ref-type="fig">Fig 1B</xref>), actin, caldesmon (<xref rid="pone.0124288.g001" ref-type="fig">Fig 1C</xref>), SMA (<xref rid="pone.0124288.g001" ref-type="fig">Fig 1D</xref>), and CD99. Estrogen and progesterone receptors&#x2019; staining was weakly positive focally. There were negative findings for AE1/AE3, CD68, CD34, EMA, S-100, and CD31. Neither atypia nor necrosis was found. There were very few mitotic figures (0&#x2013;1/10 high power field). The histological diagnosis was leiomyoma.</p>
        <fig id="pone.0124288.g001" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0124288.g001</object-id>
          <label>Fig 1</label>
          <caption>
            <title>Histological examination of the retroperitoneal leiomyoma.</title>
            <p>A) HE-stained slide showing the tumor with spindle cells with eosinophilc cytoplasm without atypia surrounded by loose fibrous stroma. B) Immunoexpression of desmin. C) Immunoexpression of caldesmon. D) Immunoexpression of SMA.</p>
          </caption>
          <graphic xlink:href="pone.0124288.g001"/>
        </fig>
      </sec>
      <sec id="sec005">
        <title>G-banding and karyotyping</title>
        <p>Fresh tissue from a representative area of the tumor was received and analyzed cytogenetically as part of our diagnostic routine. The sample was disaggregated mechanically and enzymatically with collagenase II (Worthington, Freehold, NJ, USA). The resulting cells were cultured and harvested using standard techniques. Chromosome preparations were G-banded with Wright stain and examined. The karyotype was written according to The International System for Human Cytogenetic Nomenclature (ISCN) 2009 guidelines [<xref rid="pone.0124288.ref006" ref-type="bibr">6</xref>].</p>
      </sec>
      <sec id="sec006">
        <title>Fluorescence in situ hybridization (FISH)</title>
        <p>FISH was performed on metaphase spreads using whole painting probes for chromosomes 9 and 22, a BCR/ABL(ABL1) Translocation Dual Fusion probe (Cytocell, Cambridge, UK), and an EWSR1 Breakapart probe (Cytocell, Cambridge, UK). Fluorescent signals were captured and analyzed using the CytoVision system (Leica Biosystems, Newcastle, UK).</p>
      </sec>
      <sec id="sec007">
        <title>Molecular genetic analyses</title>
        <p>Tumor tissue adjacent to that used for cytogenetic analysis and histologic examination had been frozen and stored at -80&#xB0;C. Total RNA was extracted using Trizol reagent according to the manufacturer&#x2019;s instructions (Lifetechnologies, Oslo, Norway) with the TissueLyser II homogenizer (Qiagen, Hilden, Germany).</p>
        <p>Two &#x3BC;g of total RNA were reverse-transcribed in a 20 &#x3BC;L reaction volume using iScript Advanced cDNA Synthesis Kit for RT-qPCR according to the manufacturer&#x2019;s instructions (Bio-Rad Laboratories, Oslo, Norway) and 1 &#x3BC;L was used as template in subsequent PCR assays. The 25 &#x3BC;L PCR volumes contained 12.5 &#x3BC;L of Premix Taq (Takara Bio Europe/SAS, Saint-Germain-en-Laye, France), 1 &#x3BC;L of cDNA, and 0.4 &#x3BC;M of each of the forward and reverse primers. The PCRs were run on a C-1000 Thermal cycler (Bio-Rad Laboratories). The PCR conditions for all amplifications were: an initial denaturation at 94&#xB0;C for 30 sec followed by 35 cycles of 7 sec at 98&#xB0;C and 2 min at 68&#xB0;C, and a final extension for 5 min at 68&#xB0;C. The quality of the cDNA synthesis was examined by amplification of a cDNA fragment of the <italic>ABL1</italic> gene using the primers ABL1-91F1 (<monospace>5'-CAG CGG CCA GTA GCA TCT GAC TTT G-3'</monospace>) and ABL1-404R1 (<monospace>5' CTC AGC AGA TAC TCA GCG GCA TTG C 3'</monospace>). For the detection of the <italic>EWSR1-PBX3</italic> fusion transcript, two forward <italic>EWSR1</italic> primers, EWSR1-879F (<monospace>5'- GCT ACC CCA TGC AGC CAG TCA CTG-3'</monospace>) and EWSR1-986F (<monospace>5'- TAT GGG CAA CCG AGC AGC TAT GGA-3'</monospace>), and two reverse PBX3 primers, PBX3-1198R1 (<monospace>5'-GCT CCG ACT TGG GAC CCT TGG TAA G-3'</monospace>) and PBX3-1032R1 (<monospace>5'-CAC GGC CGT CTT TGC AGC ATA GAG-3'</monospace>), were used. The following primer combinations were applied: 1) EWSR1-879F together with the primer PBX1-1198R1, 2) EWSR1-986F together with the primer PBX3-1032R1, 3) EWSR1-879F together with the primer PBX3-1032R1, and 4) EWS-986F together with the primer PBX1-1198R1.</p>
        <p>Three &#x3BC;L of the PCR products were stained with GelRed (Biotium), analyzed by electrophoresis through 1.0% agarose gel, and photographed. The remaining 22 &#x3BC;L of the PCR products were purified using the Qiagen PCR purification kit (Qiagen) and direct sequencing was performed using the light run sequencing service of GATC Biotech (<ext-link ext-link-type="uri" xlink:href="http://www.gatc-biotech.com/en/sanger-services/lightrun-sequencing.html">http://www.gatc-biotech.com/en/sanger-services/lightrun-sequencing.html</ext-link>). The BLAST software (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/BLAST/">http://www.ncbi.nlm.nih.gov/BLAST/</ext-link>) was used for computer analysis of sequence data.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="sec008">
      <title>Results</title>
      <sec id="sec009">
        <title>G-banding and FISH</title>
        <p>The G-banding analysis yielded a karyotype with only a single chromosomal abnormality: 46,XX,t(9;22)(q33;q12)[<xref rid="pone.0124288.ref010" ref-type="bibr">10</xref>]/46,XX[<xref rid="pone.0124288.ref005" ref-type="bibr">5</xref>] (<xref rid="pone.0124288.g002" ref-type="fig">Fig 2A</xref>). FISH on metaphase spreads using painting probes for chromosomes 9 and 22 confirmed the 9;22-translocation (<xref rid="pone.0124288.g002" ref-type="fig">Fig 2B</xref>). To further characterize it, FISH was performed using a commercial probe for the fusion gene <italic>BCR/ABL1</italic> (<xref rid="pone.0124288.g002" ref-type="fig">Fig 2C</xref>). The analysis showed that the entire <italic>ABL1</italic> probe (red signal) was moved to der(22) where it generated a yellow fusion signal with the BCR probe which remained intact (green signal) on both the normal 22 and on the der(22)t(9;22). This indicated that the breakpoint on the der(9)t(9;22) was proximal to the <italic>ABL1</italic> locus whereas that on the der(22)t(9;22) was distal to the <italic>BCR</italic> locus. FISH analysis with the <italic>EWSR1</italic> break apart probe (<xref rid="pone.0124288.g002" ref-type="fig">Fig 2D</xref>) showed that the red, proximal part of the probe covering the 5&#xB4;-end of the gene remained on the der(22)t(9;22) but that the green, distal part of the probe which hybridizes to the 3&#xB4;-end of the <italic>EWSR1</italic> locus, had moved to the der(9)t(9;22). Thus the combined G-banding and FISH analyses suggested a rearrangement of <italic>EWSR1</italic> with possible fusion to a gene close but proximal to the <italic>ABL1</italic> locus in 9q34.12. We therefore searched for a fusion candidate gene up to 10 Mbp proximal to <italic>ABL1</italic> using the genome browser of UCSC Genome Bioinformatics (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/index.html">http://genome.ucsc.edu/index.html</ext-link>) and found the <italic>PBX3</italic> gene (in 9q33.3), 5 Mbp upstream of <italic>ABL1</italic>, which we deemed was the strongest candidate for further investigation as a 3&#xB4;-partner in a <italic>EWSR1</italic>-fusion. This was because <italic>PBX3</italic> has extensive homology to <italic>PBX1</italic> [<xref rid="pone.0124288.ref007" ref-type="bibr">7</xref>] which has been found as a 3&#xB4;-partner in an <italic>EWSR1-PBX1</italic> fusion in myoepithelial tumors [<xref rid="pone.0124288.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0124288.ref009" ref-type="bibr">9</xref>]. Furthermore, while we were busy analyzing the present retroperitoneal leiomyoma, an article reporting <italic>EWSR1-PBX3</italic> fusion in myopethelial tumors appeared on line [<xref rid="pone.0124288.ref010" ref-type="bibr">10</xref>], further supporting the hypothesis of <italic>PBX3</italic> as a potential fusion partner of <italic>EWSR1</italic>.</p>
        <fig id="pone.0124288.g002" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0124288.g002</object-id>
          <label>Fig 2</label>
          <caption>
            <title>Cytogenetic and FISH data on the retroperitoneal leiomyoma.</title>
            <p>A) Partial karyotype showing the der(9)t(9;22)(q33;q12) and der(22)t(9;22)(q33;q12) with the corresponding normal chromosome homologs; breakpoint positions are indicated by arrows. B) FISH using whole chromosome painting probes for chromosome 9 (red signal) and 22 (green signal). C) FISH using the BCR/ABL(ABL1) Translocation Dual Fusion probe. D) FISH using the EWSR1 Breakapart probe.</p>
          </caption>
          <graphic xlink:href="pone.0124288.g002"/>
        </fig>
      </sec>
      <sec id="sec010">
        <title>Molecular genetic analysis</title>
        <p>A 338 bp <italic>ABL1</italic> cDNA fragment was amplified indicating the good quality of the synthesized cDNA (<xref rid="pone.0124288.g003" ref-type="fig">Fig 3A</xref>). RT-PCR with all four primer combinations&#x2014;EWSR1-879F/PBX3-1198R1, EWSR1-986F/PBX3-1032R1, EWSR1-879F/PBX3-1032R1, and EWSR1-986F/PBX3-1198R1&#x2014;amplified cDNA fragments strongly suggesting the presence of an <italic>EWSR1-PBX3</italic> fusion transcript in the examined tumor (<xref rid="pone.0124288.g003" ref-type="fig">Fig 3A</xref>). Sequencing of the amplified cDNA fragment obtained with the EWSR1-879F/PBX3-1198R1 primer set showed that it was an <italic>EWSR1-PBX3</italic> chimeric cDNA fragment in which exon 9 of <italic>EWSR1</italic> (nucleotide 1320 accession number NM_013986 version 3) was in-frame fused to exon 5 of <italic>PBX3</italic> (nucleotide 824 accession number NM_006195 version 5) (<xref rid="pone.0124288.g003" ref-type="fig">Fig 3B</xref>).</p>
        <fig id="pone.0124288.g003" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0124288.g003</object-id>
          <label>Fig 3</label>
          <caption>
            <title>Molecular genetic data on the retroperitoneal leiomyoma.</title>
            <p>A) Gel electrophoresis of the RT-PCR amplified products using cDNA from the tumor. B) Partial sequence chromatogram of the amplified cDNA fragment showing the fusion point in the <italic>EWSR1-PBX3</italic> fusion transcript. C) Sequence alignment of the EWSR1-PBX3 protein and EWSR1-PBX1 protein. Homeodomains are shown in yellow color.</p>
          </caption>
          <graphic xlink:href="pone.0124288.g003"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="sec011">
      <title>Discussion</title>
      <p>We describe here the presence of an <italic>EWSR1-PBX3</italic> fusion gene brought about by a 9;22-translocation in a retroperitoneal leiomyoma. The case provides an additional example of involvement of the <italic>EWSR1</italic> gene in a benign tumor. Previously, <italic>EWSR1</italic> has been found to be pathogenetically rearranged in the benign hidradenoma of the skin, myoepithelioma, and hemangioma of bone [<xref rid="pone.0124288.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0124288.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0124288.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0124288.ref012" ref-type="bibr">12</xref>], in addition to its much more common involvement in malignant tumors such as the Ewing family of tumors, desmoplastic small round cell tumor, myxoid liposarcoma, and extraskeletal myxoid chondrosarcoma [<xref rid="pone.0124288.ref013" ref-type="bibr">13</xref>&#x2013;<xref rid="pone.0124288.ref016" ref-type="bibr">16</xref>].</p>
      <p>At the genomic level, the balanced 9;22-translocation we found as the sole chromosomal change is sufficient to generate a functional <italic>EWSR1-PBX3</italic> fusion, most probable on the derivative chromosome 22, since both <italic>EWSR1</italic> (in 22q12.2) and <italic>PBX3</italic> (in 9q33.3) are transcribed from centromere to telomere. The <italic>EWSR1-PBX3</italic> fusion gene described here is identical to the <italic>EWSR1-PBX3</italic> fusion found recently in three myopethelial tumors with low mitotic activity (0&#x2013;1 per 10 high-power field) and immunohistochemically positive for S100 and EMA [<xref rid="pone.0124288.ref010" ref-type="bibr">10</xref>]. In both studies, exon 9 of <italic>EWSR1</italic> (former exon 8 in sequences with accession number X66899 and NM_005243; [<xref rid="pone.0124288.ref017" ref-type="bibr">17</xref>]) was fused to exon 5 of <italic>PBX3</italic>. <italic>EWSR1-PBX3</italic> is similar in this regard to other fusion genes involving <italic>EWSR1</italic>, such as <italic>EWSR1-ATF1</italic>, <italic>EWSR1-PBX1</italic>, and <italic>EWSR1-ZNF444</italic> [<xref rid="pone.0124288.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0124288.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0124288.ref019" ref-type="bibr">19</xref>]. Hence, <italic>EWSR1</italic> appears to have a mechanism of action in <italic>EWSR1-PBX3</italic> similar to that in the other <italic>EWSR1</italic>-involving fusions [<xref rid="pone.0124288.ref020" ref-type="bibr">20</xref>].</p>
      <p><italic>PBX1</italic> on 1q23.3, <italic>PBX2</italic> on 6p21.32, <italic>PBX3</italic> on 9q33.3, and <italic>PBX4</italic> on 19p13.11 code for the four members of the human PBX family of transcription factors [<xref rid="pone.0124288.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0124288.ref021" ref-type="bibr">21</xref>]. The <italic>PBX</italic> genes are known to regulate genes involved in the differentiation of urogenital organs and steroidogenesis through their ability to form hetero-oligomeric DNA complexes [<xref rid="pone.0124288.ref022" ref-type="bibr">22</xref>]. PBX proteins interact with a subset of HOX proteins resulting in increased DNA-binding affinity of HOX proteins thereby enhancing the transcription of downstream target genes [<xref rid="pone.0124288.ref023" ref-type="bibr">23</xref>]. In 1990, the prototype PBX1 transcription factor of the PBX family was identified based on its involvement in the t(1;19)(q23;p13) translocation seen most often in pre-B ALL [<xref rid="pone.0124288.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0124288.ref025" ref-type="bibr">25</xref>]. The t(1;19) generates the <italic>TCF3-PBX1</italic> fusion gene which codes for a chimeric protein where the N-terminal transactivation domain of TCF3 is fused to the C-terminal DNA binding homeodomain of PBX1. <italic>PBX2</italic>, <italic>PBX3</italic>, and <italic>PBX4</italic> were cloned as homologous to <italic>PBX1</italic> [<xref rid="pone.0124288.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0124288.ref021" ref-type="bibr">21</xref>]. The homeodomain of PBX3 shows 97% identity to the homeodomain of PBX1, 94% identity from amino acids 38 to 311, a region which includes the homeodomain, and 100% identity at the extreme C terminus. The overall identity between PBX1 and PBX3 is 84% [<xref rid="pone.0124288.ref007" ref-type="bibr">7</xref>]. In vitro experiments showed that PBX2 and PBX3 can be converted to oncoproteins by fusion with TCF3. Artificial TCF3-PBX2 and TCF3-PBX3 fusions, with the same part of TCF3 (amino acids 1 to 477) which is fused to PBX1 in t(1;19)-acute leukemias, displayed focus forming properties in NIH 3T3 fibroblasts comparable to those of the TCF3-PBX1 chimera, whereas none of the wild-type PBX2 and PBX3 proteins resulted in transformation of NIH 3T3 cells [<xref rid="pone.0124288.ref026" ref-type="bibr">26</xref>]. These results demonstrated that all three proteins, PBX1, PBX2, and PBX3, possess latent transforming properties that are similar in potency and dependence on fusion with TCF3 [<xref rid="pone.0124288.ref026" ref-type="bibr">26</xref>].</p>
      <p>Information about the involvement of the <italic>PBX3</italic> gene in cancer is nevertheless limited. Recently, <italic>PBX3</italic> was found to be overexpressed in gastric cancer and to regulate cell proliferation [<xref rid="pone.0124288.ref027" ref-type="bibr">27</xref>]. In prostate cancer, expression of <italic>PBX3</italic> was found to be regulated by androgen and Let-7d [<xref rid="pone.0124288.ref028" ref-type="bibr">28</xref>]. In colorectal cancer, <italic>PBX3</italic> mRNA was negatively correlated with Let-7c levels so that <italic>PBX3</italic> could reverse the suppression growth effects of Let-7c [<xref rid="pone.0124288.ref029" ref-type="bibr">29</xref>]. The PBX3 protein was also found to be a critical cofactor of HOXA9 in leukemogenesis, and targeting of the interaction between the two proteins was deemed to be a feasible strategy to treat acute myeloid leukemia with <italic>PBX3</italic> gene overexpression [<xref rid="pone.0124288.ref030" ref-type="bibr">30</xref>].</p>
      <p>Based on the <italic>EWSR1</italic> sequence with accession number NM_013986 version 3 and <italic>PBX3</italic> sequence with accession number NM_006195 version 5, the <italic>EWSR1-PBX3</italic> fusion transcript found here would be 3408 bp long and would code for 529 amino acids of chimeric EWSR1-PBX3 protein which contains the N-terminal transactivation part of the EWSR1 protein and the homeodomain of the PBX3 protein. In myoepitheliomas with t(1;22) and the <italic>EWSR1-PBX1</italic> fusion gene, two transcripts were reported: one in-frame and, hence, supposedly pathogenetically crucial, with fusion between exon 9 (exon 8 in sequences with accession number X66899 and NM_005243) of <italic>EWSR1</italic> and exon 5 of <italic>PBX1</italic>, the other out-of-frame with a fusion between exon 8 (exon 7 in sequences with accession number X66899 and NM_005243) of <italic>EWSR1</italic> and exon 5 of <italic>PBX1</italic>; this one is presumably pathogenetically unimportant [<xref rid="pone.0124288.ref009" ref-type="bibr">9</xref>]. The <italic>EWSR1-PBX3</italic> and the in-frame <italic>EWSR1-PBX1</italic> fusion transcripts code for proteins with high level of identity (<xref rid="pone.0124288.g003" ref-type="fig">Fig 3C</xref>) and, in principle, confirm the conclusions stemming from experiments with artificial TCF3-PBX2 and TCF3-PBX3 fusions [<xref rid="pone.0124288.ref026" ref-type="bibr">26</xref>].</p>
      <p>The present study together with our previous work in which a retroperitoneal leiomyoma with a t(10;17)(q22;q21) as the sole karyotypic aberration was shown to have a <italic>KAT6B</italic>-<italic>KANSL1</italic> fusion gene, indicate that retroperitoneal leiomyomas may carry fusion genes coding for chimeric proteins. To what extent molecular heterogeneity exists in retroperitoneal leiomyomagenesis reflecting various pathogenetic pathways, is still largely unknown. Likewise, whether any pathogenetic differences exist between uterine and retroperitoneal leiomyomas remains to be studied more thoroughly.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors thank Saeedeh Shahmohammadi for technical help.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pone.0124288.ref001">
        <label>1</label>
        <mixed-citation publication-type="journal"><name><surname>Billings</surname><given-names>SD</given-names></name>, <name><surname>Folpe</surname><given-names>AL</given-names></name>, <name><surname>Weiss</surname><given-names>SW</given-names></name>. <article-title>Do leiomyomas of deep soft tissue exist? An analysis of highly differentiated smooth muscle tumors of deep soft tissue supporting two distinct subtypes</article-title>. <source>Am J Surg Pathol</source>. <year>2001</year>;<volume>25</volume>: <fpage>1134</fpage>&#x2013;<lpage>1142</lpage>. <pub-id pub-id-type="pmid">11688572</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref002">
        <label>2</label>
        <mixed-citation publication-type="journal"><name><surname>Paal</surname><given-names>E</given-names></name>, <name><surname>Miettinen</surname><given-names>M</given-names></name>. <article-title>Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas</article-title>. <source>Am J Surg Pathol</source>. <year>2001</year>;<volume>25</volume>: <fpage>1355</fpage>&#x2013;<lpage>1363</lpage>. <pub-id pub-id-type="pmid">11684951</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref003">
        <label>3</label>
        <mixed-citation publication-type="journal"><name><surname>Poliquin</surname><given-names>V</given-names></name>
, <name><surname>Victory</surname><given-names>R</given-names></name>, <name><surname>Vilos</surname><given-names>GA</given-names></name>. <article-title>Epidemiology, presentation, and management of retroperitoneal leiomyomata: systematic literature review and case report</article-title>. <source>J Minim Invasive Gynecol</source>. <year>2008</year>;<volume>15</volume>: <fpage>152</fpage>&#x2013;<lpage>160</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jmig.2007.12.009">10.1016/j.jmig.2007.12.009</ext-link></comment>
<pub-id pub-id-type="pmid">18312983</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref004">
        <label>4</label>
        <mixed-citation publication-type="book"><name><surname>Fletcher</surname><given-names>CDM</given-names></name>, <name><surname>Bridge</surname><given-names>JA</given-names></name>, <name><surname>Hogendoorn</surname><given-names>PCW</given-names></name>, <name><surname>Mertens</surname><given-names>F</given-names></name>. <source>WHO Classification of Tumours of Soft Tissue and Bone</source>. <publisher-loc>Lyon</publisher-loc>: <publisher-name>IARC</publisher-name>; <year>2013</year>.</mixed-citation>
      </ref>
      <ref id="pone.0124288.ref005">
        <label>5</label>
        <mixed-citation publication-type="journal"><name><surname>Panagopoulos</surname><given-names>I</given-names></name>, <name><surname>Gorunova</surname><given-names>L</given-names></name>, <name><surname>Bjerkehagen</surname><given-names>B</given-names></name>, <name><surname>Heim</surname><given-names>S</given-names></name>. <article-title>Novel <italic>KAT6B-KANSL1</italic> Fusion Gene Identified by RNA Sequencing in Retroperitoneal Leiomyoma with t(10;17)(q22;q21)</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>: <fpage>e0117010</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0117010">10.1371/journal.pone.0117010</ext-link></comment>
<pub-id pub-id-type="pmid">25621995</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref006">
        <label>6</label>
        <mixed-citation publication-type="book"><name><surname>Schaffer</surname><given-names>LG</given-names></name>, <name><surname>Slovak</surname><given-names>ML</given-names></name>, <name><surname>Campbell</surname><given-names>LJ</given-names></name>. <source>ISCN 2009: an International System for Human Cytogenetic Nomenclature</source>. <publisher-loc>Basel</publisher-loc>: <publisher-name>Karger</publisher-name>; <year>2009</year>.</mixed-citation>
      </ref>
      <ref id="pone.0124288.ref007">
        <label>7</label>
        <mixed-citation publication-type="journal"><name><surname>Monica</surname><given-names>K</given-names></name>, <name><surname>Galili</surname><given-names>N</given-names></name>, <name><surname>Nourse</surname><given-names>J</given-names></name>, <name><surname>Saltman</surname><given-names>D</given-names></name>, <name><surname>Cleary</surname><given-names>ML</given-names></name>. <article-title><italic>PBX2</italic> and <italic>PBX3</italic>, new homeobox genes with extensive homology to the human proto-oncogene <italic>PBX1</italic></article-title>. <source>Mol Cell Biol</source>. <year>1991</year>;<volume>11</volume>: <fpage>6149</fpage>&#x2013;<lpage>6157</lpage>. <pub-id pub-id-type="pmid">1682799</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref008">
        <label>8</label>
        <mixed-citation publication-type="journal"><name><surname>Antonescu</surname><given-names>CR</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Chang</surname><given-names>NE</given-names></name>, <name><surname>Pawel</surname><given-names>BR</given-names></name>, <name><surname>Travis</surname><given-names>W</given-names></name>, <name><surname>Katabi</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title><italic>EWSR1-POU5F1</italic> fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the <italic>EWSR1</italic> gene</article-title>. <source>Genes Chromosomes Cancer</source>, <year>2010</year>;<volume>49</volume>: <fpage>1114</fpage>&#x2013;<lpage>1124</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/gcc.20819">10.1002/gcc.20819</ext-link></comment>
<pub-id pub-id-type="pmid">20815032</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref009">
        <label>9</label>
        <mixed-citation publication-type="journal"><name><surname>Brandal</surname><given-names>P</given-names></name>, <name><surname>Panagopoulos</surname><given-names>I</given-names></name>, <name><surname>Bjerkehagen</surname><given-names>B</given-names></name>, <name><surname>Gorunova</surname><given-names>L</given-names></name>, <name><surname>Skjeldal</surname><given-names>S</given-names></name>, <name><surname>Micci</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Detection of a t(1;22)(q23;q12) translocation leading to an <italic>EWSR1-PBX1</italic> fusion gene in a myoepithelioma</article-title>. <source>Genes Chromosomes Cancer</source>. <year>2008</year>;<volume>47</volume>: <fpage>558</fpage>&#x2013;<lpage>564</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/gcc.20559">10.1002/gcc.20559</ext-link></comment>
<pub-id pub-id-type="pmid">18383210</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref010">
        <label>10</label>
        <mixed-citation publication-type="journal"><name><surname>Agaram</surname><given-names>NP</given-names></name>, <name><surname>Chen</surname><given-names>HW</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Sung</surname><given-names>YS</given-names></name>, <name><surname>Panicek</surname><given-names>D</given-names></name>, <name><surname>Healey</surname><given-names>JH</given-names></name>, <etal>et al</etal>
<article-title><italic>EWSR1-PBX3</italic>: A novel gene fusion in myoepithelial tumors</article-title>. <source>Genes Chromosomes Cancer</source>. <year>2014</year>;<volume>54</volume>: <fpage>63</fpage>&#x2013;<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/gcc.22216">10.1002/gcc.22216</ext-link></comment>
<pub-id pub-id-type="pmid">25231231</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref011">
        <label>11</label>
        <mixed-citation publication-type="journal"><name><surname>Arbajian</surname><given-names>E</given-names></name>, <name><surname>Magnusson</surname><given-names>L</given-names></name>, <name><surname>Brosj&#xF6;</surname><given-names>O</given-names></name>, <name><surname>Wejde</surname><given-names>J</given-names></name>, <name><surname>Folpe</surname><given-names>AL</given-names></name>, <name><surname>Nord</surname><given-names>KH</given-names></name>, <etal>et al</etal>
<article-title>A benign vascular tumor with a new fusion gene: <italic>EWSR1-NFATC1</italic> in hemangioma of the bone</article-title>. <source>Am J Surg Pathol</source>. <year>2013</year>;<volume>37</volume>: <fpage>613</fpage>&#x2013;<lpage>616</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/PAS.0b013e31827ae13b">10.1097/PAS.0b013e31827ae13b</ext-link></comment>
<pub-id pub-id-type="pmid">23480895</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref012">
        <label>12</label>
        <mixed-citation publication-type="journal"><name><surname>M&#xF6;ller</surname><given-names>E</given-names></name>, <name><surname>Stenman</surname><given-names>G</given-names></name>, <name><surname>Mandahl</surname><given-names>N</given-names></name>, <name><surname>Hamberg</surname><given-names>H</given-names></name>, <name><surname>M&#xF6;lne</surname><given-names>L</given-names></name>, <name><surname>van den Oord</surname><given-names>JJ</given-names></name>, <etal>et al</etal>
<article-title><italic>POU5F1</italic>, encoding a key regulator of stem cell pluripotency, is fused to <italic>EWSR1</italic> in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands</article-title>. <source>J Pathol</source>. <year>2008</year>;<volume>215</volume>: <fpage>78</fpage>&#x2013;<lpage>86</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/path.2327">10.1002/path.2327</ext-link></comment>
<pub-id pub-id-type="pmid">18338330</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref013">
        <label>13</label>
        <mixed-citation publication-type="journal"><name><surname>Delattre</surname><given-names>O</given-names></name>, <name><surname>Zucman</surname><given-names>J</given-names></name>, <name><surname>Plougastel</surname><given-names>B</given-names></name>, <name><surname>Desmaze</surname><given-names>C</given-names></name>, <name><surname>Melot</surname><given-names>T</given-names></name>, <name><surname>Peter</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours</article-title>. <source>Nature</source>. <year>1992</year>;<volume>359</volume>: <fpage>162</fpage>&#x2013;<lpage>165</lpage>. <pub-id pub-id-type="pmid">1522903</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref014">
        <label>14</label>
        <mixed-citation publication-type="journal"><name><surname>Labelle</surname><given-names>Y</given-names></name>, <name><surname>Zucman</surname><given-names>J</given-names></name>, <name><surname>Stenman</surname><given-names>G</given-names></name>, <name><surname>Kindblom</surname><given-names>LG</given-names></name>, <name><surname>Knight</surname><given-names>J</given-names></name>, <name><surname>Turc-Carel</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation</article-title>. <source>Hum Mol Genet</source>. <year>1995</year>;<volume>4</volume>: <fpage>2219</fpage>&#x2013;<lpage>2226</lpage>. <pub-id pub-id-type="pmid">8634690</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref015">
        <label>15</label>
        <mixed-citation publication-type="journal"><name><surname>Ladanyi</surname><given-names>M</given-names></name>, <article-title>Gerald W Fusion of the <italic>EWS</italic> and <italic>WT1</italic> genes in the desmoplastic small round cell tumor</article-title>. <source>Cancer Res</source>. <year>1994</year>;<volume>54</volume>: <fpage>2837</fpage>&#x2013;<lpage>2840</lpage>. <pub-id pub-id-type="pmid">8187063</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref016">
        <label>16</label>
        <mixed-citation publication-type="journal"><name><surname>Panagopoulos</surname><given-names>I</given-names></name>, <name><surname>H&#xF6;glund</surname><given-names>M</given-names></name>, <name><surname>Mertens</surname><given-names>F</given-names></name>, <name><surname>Mandahl</surname><given-names>N</given-names></name>, <name><surname>Mitelman</surname><given-names>F</given-names></name>, <name><surname>&#xC5;man</surname><given-names>P</given-names></name>. <article-title>Fusion of the <italic>EWS</italic> and <italic>CHOP</italic> genes in myxoid liposarcoma</article-title>. <source>Oncogene</source>. <year>1996</year>;<volume>12</volume>: <fpage>489</fpage>&#x2013;<lpage>494</lpage>. <pub-id pub-id-type="pmid">8637704</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref017">
        <label>17</label>
        <mixed-citation publication-type="journal"><name><surname>Plougastel</surname><given-names>B</given-names></name>, <name><surname>Zucman</surname><given-names>J</given-names></name>, <name><surname>Peter</surname><given-names>M</given-names></name>, <name><surname>Thomas</surname><given-names>G</given-names></name>, <name><surname>Delattre</surname><given-names>O</given-names></name>. <article-title>Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation</article-title>. <source>Genomics</source>. <year>1993</year>;<volume>18</volume>: <fpage>609</fpage>&#x2013;<lpage>615</lpage>. <pub-id pub-id-type="pmid">8307570</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref018">
        <label>18</label>
        <mixed-citation publication-type="journal"><name><surname>Brandal</surname><given-names>P</given-names></name>, <name><surname>Panagopoulos</surname><given-names>I</given-names></name>, <name><surname>Bjerkehagen</surname><given-names>B</given-names></name>, <name><surname>Heim</surname><given-names>S</given-names></name>. <article-title>t(19;22)(q13;q12) Translocation leading to the novel fusion gene <italic>EWSR1-ZNF444</italic> in soft tissue myoepithelial carcinoma</article-title>. <source>Genes Chromosomes Cancer</source>. <year>2009</year>;<volume>48</volume>: <fpage>1051</fpage>&#x2013;<lpage>1056</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/gcc.20706">10.1002/gcc.20706</ext-link></comment>
<pub-id pub-id-type="pmid">19760602</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref019">
        <label>19</label>
        <mixed-citation publication-type="journal"><name><surname>Panagopoulos</surname><given-names>I</given-names></name>, <name><surname>Mertens</surname><given-names>F</given-names></name>, <name><surname>Debiec-Rychter</surname><given-names>M</given-names></name>, <name><surname>Isaksson</surname><given-names>M</given-names></name>, <name><surname>Limon</surname><given-names>J</given-names></name>, <name><surname>Kardas</surname><given-names>I</given-names></name>, <etal>et al</etal>
<article-title>Molecular genetic characterization of the <italic>EWS/ATF1</italic> fusion gene in clear cell sarcoma of tendons and aponeuroses</article-title>. <source>Int J Cancer</source>. <year>2002</year>;<volume>99</volume>: <fpage>560</fpage>&#x2013;<lpage>567</lpage>. <pub-id pub-id-type="pmid">11992546</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref020">
        <label>20</label>
        <mixed-citation publication-type="journal"><name><surname>Fisher</surname><given-names>C</given-names></name>. <article-title>The diversity of soft tissue tumours with <italic>EWSR1</italic> gene rearrangements: a review</article-title>. <source>Histopathology</source>. <year>2014</year>;<volume>64</volume>: <fpage>134</fpage>&#x2013;<lpage>150</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/his.12269">10.1111/his.12269</ext-link></comment>
<pub-id pub-id-type="pmid">24320889</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref021">
        <label>21</label>
        <mixed-citation publication-type="journal"><name><surname>Wagner</surname><given-names>K</given-names></name>, <name><surname>Mincheva</surname><given-names>A</given-names></name>, <name><surname>Korn</surname><given-names>B</given-names></name>, <name><surname>Lichter</surname><given-names>P</given-names></name>, <name><surname>Popperl</surname><given-names>H</given-names></name>. <article-title>Pbx4, a new Pbx family member on mouse chromosome 8, is expressed during spermatogenesis</article-title>. <source>Mech Dev</source>. <year>2001</year>;<volume>103</volume>: <fpage>127</fpage>&#x2013;<lpage>131</lpage>. <pub-id pub-id-type="pmid">11335119</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref022">
        <label>22</label>
        <mixed-citation publication-type="journal"><name><surname>Laurent</surname><given-names>A</given-names></name>, <name><surname>Bihan</surname><given-names>R</given-names></name>, <name><surname>Omilli</surname><given-names>F</given-names></name>, <name><surname>Deschamps</surname><given-names>S</given-names></name>, <name><surname>Pellerin</surname><given-names>I</given-names></name>. <article-title>PBX proteins: much more than Hox cofactors</article-title>. <source>Int J Dev Biol</source>. <year>2008</year>;<volume>52</volume>: <fpage>9</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="pmid">18033668</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref023">
        <label>23</label>
        <mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>CP</given-names></name>, <name><surname>Brocchieri</surname><given-names>L</given-names></name>, <name><surname>Shen</surname><given-names>WF</given-names></name>, <name><surname>Largman</surname><given-names>C</given-names></name>, <name><surname>Cleary</surname><given-names>ML</given-names></name>. <article-title>Pbx modulation of Hox homeodomain amino-terminal arms establishes different DNA-binding specificities across the Hox locus</article-title>. <source>Mol Cell Biol</source>. <year>1996</year>;<volume>16</volume>: <fpage>1734</fpage>&#x2013;<lpage>1745</lpage>. <pub-id pub-id-type="pmid">8657149</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref024">
        <label>24</label>
        <mixed-citation publication-type="journal"><name><surname>Kamps</surname><given-names>MP</given-names></name>, <name><surname>Murre</surname><given-names>C</given-names></name>, <name><surname>Sun</surname><given-names>XH</given-names></name>, <name><surname>Baltimore</surname><given-names>D</given-names></name>. <article-title>A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL</article-title>. <source>Cell</source>. <year>1990</year>;<volume>60</volume>: <fpage>547</fpage>&#x2013;<lpage>555</lpage>. <pub-id pub-id-type="pmid">1967983</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref025">
        <label>25</label>
        <mixed-citation publication-type="journal"><name><surname>Nourse</surname><given-names>J</given-names></name>, <name><surname>Mellentin</surname><given-names>JD</given-names></name>, <name><surname>Galili</surname><given-names>N</given-names></name>, <name><surname>Wilkinson</surname><given-names>J</given-names></name>, <name><surname>Stanbridge</surname><given-names>E</given-names></name>, <name><surname>Smith</surname><given-names>SD</given-names></name>, <etal>et al</etal>
<article-title>Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor</article-title>. <source>Cell</source>, <year>1990</year>;<volume>60</volume>: <fpage>535</fpage>&#x2013;<lpage>545</lpage>. <pub-id pub-id-type="pmid">1967982</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref026">
        <label>26</label>
        <mixed-citation publication-type="journal"><name><surname>Monica</surname><given-names>K</given-names></name>, <name><surname>LeBrun</surname><given-names>DP</given-names></name>, <name><surname>Dedera</surname><given-names>DA</given-names></name>, <name><surname>Brown</surname><given-names>R</given-names></name>, <name><surname>Cleary</surname><given-names>ML</given-names></name>. <article-title>Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable</article-title>. <source>Mol Cell Biol</source>. <year>1994</year>;<volume>14</volume>: <fpage>8304</fpage>&#x2013;<lpage>8314</lpage>. <pub-id pub-id-type="pmid">7969166</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref027">
        <label>27</label>
        <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Sun</surname><given-names>Z</given-names></name>, <name><surname>Zhu</surname><given-names>Z</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Sun</surname><given-names>X</given-names></name>, <name><surname>Xu</surname><given-names>H</given-names></name>. <article-title>PBX3 is overexpressed in gastric cancer and regulates cell proliferation</article-title>. <source>Tumour Biol</source>. <year>2014</year>;<volume>35</volume>: <fpage>4363</fpage>&#x2013;<lpage>4368</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s13277-013-1573-6">10.1007/s13277-013-1573-6</ext-link></comment>
<pub-id pub-id-type="pmid">24375258</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref028">
        <label>28</label>
        <mixed-citation publication-type="journal"><name><surname>Ramberg</surname><given-names>H</given-names></name>, <name><surname>Alshbib</surname><given-names>A</given-names></name>, <name><surname>Berge</surname><given-names>V</given-names></name>, <name><surname>Svindland</surname><given-names>A</given-names></name>, <name><surname>Tasken</surname><given-names>KA</given-names></name>. <article-title>Regulation of PBX3 expression by androgen and Let-7d in prostate cancer</article-title>. <source>Mol Cancer</source>. <year>2011</year>;<volume>10</volume>: <fpage>50</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1476-4598-10-50">10.1186/1476-4598-10-50</ext-link></comment>
<pub-id pub-id-type="pmid">21548940</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref029">
        <label>29</label>
        <mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>HB</given-names></name>, <name><surname>Gu</surname><given-names>J</given-names></name>, <name><surname>Zuo</surname><given-names>HJ</given-names></name>, <name><surname>Chen</surname><given-names>ZG</given-names></name>, <name><surname>Zhao</surname><given-names>W</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer</article-title>. <source>J Pathol</source>. <year>2012</year>;<volume>226</volume>: <fpage>544</fpage>&#x2013;<lpage>555</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/path.3014">10.1002/path.3014</ext-link></comment>
<pub-id pub-id-type="pmid">21984339</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0124288.ref030">
        <label>30</label>
        <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Arnovitz</surname><given-names>S</given-names></name>, <name><surname>Chen</surname><given-names>P</given-names></name>, <name><surname>Huang</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>PBX3 is an important cofactor of HOXA9 in leukemogenesis</article-title>. <source>Blood</source>. <year>2013</year>;<volume>121</volume>: <fpage>1422</fpage>&#x2013;<lpage>1431</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1182/blood-2012-07-442004">10.1182/blood-2012-07-442004</ext-link></comment>
<pub-id pub-id-type="pmid">23264595</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
